Mira Hormone Monitor, Mira Android App Weak Authentication
cve-program · CVE-2026-68067
PublishedThe login endpoint on the Mira cloud API accepts any format-valid string in the password field and returns a live active session token for the account matching the supplied email address. An attacker could use an email address to control cloud accounts and access hormone record information and account settings.
Read the publisher's advisoryAffected versions, risk and source history
Exploitation and risk
Source statusCISA KEV lists vulnerabilities known to be exploited. FIRST EPSS estimates the likelihood of exploitation in the next 30 days. An unavailable score does not mean zero risk.
Which CVEs have scores here?
This view includes predictions for CVE identifiers explicitly listed in public NuGet advisories. Microsoft release pages have their own prediction coverage. Check source status for the scope and latest checks.
No exploitation or prediction data is available here for these CVEs. This does not mean they are safe or unlikely to be exploited.
cve-program · CVE-2026-68067
PublishedMira Hormone Monitor, Mira Android App Weak Authentication
The login endpoint on the Mira cloud API accepts any format-valid string in the password field and returns a live active session token for the account matching the supplied email address. An attacker could use an email address to control cloud accounts and access hormone record information and account settings.
- Source published
- 11 Aug 2026 21:23:05 UTC
- Source modified
- 12 Aug 2026 12:53:26 UTC
- Saved here
- 23 Oct 2026 15:48:27 UTC
- Source terms
- CVE Program Terms of Use
Original source record · Cite this exact observation · Complete original publisher JSON
Source: cve-program · CVE Program Terms of Use. The publisher's wording is preserved. ChangeIntel groups the information and labels changes. The JSON record includes additional source fields.
CVSS 4.0 · 9.3 CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
CVSS 3.1 · 9.8 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H